tiprankstipranks
Sana Biotechnology (SANA)
NASDAQ:SANA
US Market

Sana Biotechnology (SANA) Income Statement

Compare
527 Followers

Sana Biotechnology Income Statement

Last quarter (Q3 2024), Sana Biotechnology's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Sana Biotechnology's net income was $-59.92M. See Sana Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -30.86M$ -27.73M$ -17.91M$ -10.17M$ -3.92M
Operating Expenses
$ 294.94M$ 272.56M$ 356.91M$ 286.15M$ 141.15M
Depreciation and Amortization
$ 30.86M$ 27.73M$ 17.91M$ 10.17M$ 3.92M
EBITDA
$ -252.39M$ -256.94M$ -356.91M$ -287.03M$ -138.90M
Operating Income
$ -326.90M$ -272.56M$ -356.91M$ -286.15M$ -141.15M
Other Income/Expenses
$ 43.65M$ 3.09M$ 981.00K$ 844.00K$ 2.83M
Pretax Income
$ -283.25M$ -269.48M$ -355.93M$ -285.31M$ -138.32M
Net Income
$ -283.25M$ -266.39M$ -344.18M$ -278.64M$ -130.78M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.46$ -1.41$ -2.07$ -1.49$ -0.70
Diluted EPS
$ -1.46$ -1.41$ -2.07$ -1.49$ -0.70
Weighted Average Shares Outstanding
194.54M 188.34M 166.43M 187.51M 187.34M
Weighted Average Shares Outstanding (Diluted)
194.54M 188.34M 166.43M 187.51M 187.34M
Currency in USD

Sana Biotechnology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis